Literature DB >> 11597519

The growth hormone-insulin-like growth factor-I axis and colorectal cancer.

S A Bustin1, P J Jenkins.   

Abstract

The growth hormone (GH)-insulin-like growth factor (IGF)-I axis is an important modulator of growth and development, but in addition to their classical role as endocrine hormones, its components also regulate a wide range of biological functions through paracrine and autocrine mechanisms. Their potent mitogenic and anti-apoptotic effects play a critical role in the regulation of rapidly renewing epithelial cell populations such as those found in the colon. Recent evidence suggests an association between inappropriate regulation of the GH-IGF-I axis and the development of colorectal cancer. However, the molecular mechanisms and signalling pathways responsible are only beginning to be unravelled, as are the relative contributions of the endocrine and autocrine or paracrine effects.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11597519     DOI: 10.1016/s1471-4914(01)02104-9

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  23 in total

1.  Plasma levels of insulin-like growth factor-1 and insulin-like growth factor binding protein-3 in women with cervical neoplasia.

Authors:  Si Won Lee; Soo Yoon Lee; Sa Ra Lee; Woong Ju; Seung Cheol Kim
Journal:  J Gynecol Oncol       Date:  2010-09-28       Impact factor: 4.401

Review 2.  The insulin-like growth factor system and colorectal cancer: clinical and experimental evidence.

Authors:  M Davies; S Gupta; G Goldspink; M Winslet
Journal:  Int J Colorectal Dis       Date:  2005-06-16       Impact factor: 2.571

Review 3.  Extrapituitary growth hormone.

Authors:  S Harvey
Journal:  Endocrine       Date:  2010-10-23       Impact factor: 3.633

Review 4.  Role of the GH/IGF-1 axis in lifespan and healthspan: lessons from animal models.

Authors:  Darlene E Berryman; Jens Sandahl Christiansen; Gudmundur Johannsson; Michael O Thorner; John J Kopchick
Journal:  Growth Horm IGF Res       Date:  2008-08-16       Impact factor: 2.372

5.  Insulin-like growth factor-1 and childhood cancer risk.

Authors:  Mohamed Badr; Tamer Hassan; Shereen El Tarhony; Wael Metwally
Journal:  Oncol Lett       Date:  2010-09-08       Impact factor: 2.967

6.  Sugars and risk of mortality in the NIH-AARP Diet and Health Study.

Authors:  Natasha Tasevska; Yikyung Park; Li Jiao; Albert Hollenbeck; Amy F Subar; Nancy Potischman
Journal:  Am J Clin Nutr       Date:  2014-02-19       Impact factor: 7.045

7.  Cell-specific effects of insulin receptor substrate-1 deficiency on normal and IGF-I-mediated colon growth.

Authors:  J G Simmons; Y Ling; H Wilkins; C R Fuller; A J D'Ercole; James Fagin; P K Lund
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2007-09-06       Impact factor: 4.052

8.  In-vivo transfection of pcDNA3.1-IGFBP7 inhibits melanoma growth in mice through apoptosis induction and VEGF downexpression.

Authors:  Rong-Yi Chen; Hong-Xiang Chen; Jia-Xi Lin; Wei-Bing She; Ping Jiang; Li Xu; Ya-Ting Tu
Journal:  J Exp Clin Cancer Res       Date:  2010-02-16

9.  Do long-lived mutant and calorie-restricted mice share common anti-aging mechanisms?--a pathological point of view.

Authors:  Yuji Ikeno; Christie M Lew; Lisa A Cortez; Celeste R Webb; Shuko Lee; Gene B Hubbard
Journal:  Age (Dordr)       Date:  2006-06-02

10.  Analysis of circulating insulin-like growth factor-1 (IGF-1) and IGF binding protein-3 (IGFBP-3) in tobacco smokers and non-smokers.

Authors:  R M Palmer; R F Wilson; P Y Coward; D A Scott
Journal:  Tob Induc Dis       Date:  2002-06-15       Impact factor: 2.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.